Global Antibody Drug Conjugates (ADC) Market to 2032
Overview
The Global Antibody Drug Conjugates (ADC) Market is expected to reach a 34.32 USD Billion by 2032 and is projected to grow at a CAGR of 15.59% from 2025 to 2032.
Revenue, 2024 (USD Billion)
10.77
Forecast, 2032 (USD Billion)
34.32
CAGR, 2024 - 2032
15.59%
Report Coverage
Global
Global Antibody Drug Conjugates (ADC) Market 2018-2032 USD Billion
Global Antibody Drug Conjugates (ADC) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 10.77 USD Billion
- Projected Market Size (2032): 34.32 USD Billion
- CAGR (2025-2032): 15.59%
Key Findings of Global Antibody Drug Conjugates (ADC) Market
- The Global Antibody Drug Conjugates (ADC) Market was valued at 34.32 USD Billion in 2024.
- The Global Antibody Drug Conjugates (ADC) Market is likely to grow at a CAGR of 15.59% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Cleavable Linkers in Linkers Component Segment accounted for the largest share of the market with a revenue of 8.54 USD Billion
- The fastest growing segment Ambulatory Centers in End User Segment grew Fastest with a CAGR of 16.73% during the forecast period from 2024 to 2032.
Global Antibody Drug Conjugates (ADC) Market Scope
Global Antibody Drug Conjugates (ADC) Market Segmentation & Scope
Conjugation Technology
- Chemical Conjugation
- Site-Specific Conjugation
End User
- Hospitals
- Specialty Center
- Clinics
- Ambulatory Centers
- Home Healthcare
- Others
Indication
- Others
- Genitourinary Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Lung Cancer
- Blood Cancer (Leukemia, Lymphoma)
- Breast Cancer
Product
- Enhertu
- Kadcyla
- Trodelvy
- Polivy
- Adcetris
- Padcev
- Besponsa
- Elahere
- Zylonta
- Mylotarg
- Tivdak
- Others
Distribution Channel
- Others
- Retail Sales
- Direct Tenders
Linkers Component
- Non Cleavable Linkers
- Cleavable Linkers
Cytotoxic Payloads or Warheads Component
- DNA Damaging Agents
- Microtubule Disrupting Agents
Linker Technology
- Peptide Linkers
- Thioether Linkers
- Hydrazone Linkers
- Disulfide Linkers
Antibody Component
- First Generation ADCs
- Third Generation ADCs
- Second Generation ADCs
- Fourth Generation ADCs
Antigen Component
- HER2 Receptor
- Trop-2
- CD79B
- CD30
- Nectin 4
- CD19
- CD33
- Tissue Factors
- Others
- CD22
Global Antibody Drug Conjugates (ADC) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2023 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 10.77 USD Billion |
| Market Value in 2032 | 34.32 USD Billion |
| CAGR (2025-2032) | 15.59% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Conjugation Technology,End User,Indication,Product,Distribution Channel,Linkers Component,Cytotoxic Payloads or Warheads Component,Linker Technology,Antibody Component,Antigen Component |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 10.77 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 3,915.63 USD Million in 2024.
Segments and Scope
-
Global Antibody Drug Conjugates (ADC) Market to 2032, By Conjugation Technology
- Site-Specific Conjugation is the largest segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 6.06 USD Billion in the year 2024.
- Site-Specific Conjugation is the Fastest growing segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 16.05 % in forecast period 2025-2032.
-
Global Antibody Drug Conjugates (ADC) Market to 2032, By End User
- Hospitals is the largest segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 6.44 USD Billion in the year 2024.
- Ambulatory Centers is the Fastest growing segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.22 % in forecast period 2025-2032.
-
Global Antibody Drug Conjugates (ADC) Market to 2032, By Indication
- Breast Cancer is the largest segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 4.58 USD Billion in the year 2024.
- Breast Cancer is the Fastest growing segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 16.22 % in forecast period 2025-2032.
-
Global Antibody Drug Conjugates (ADC) Market to 2032, By Product
- Enhertu is the largest segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 4.22 USD Billion in the year 2024.
- Enhertu is the Fastest growing segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 16.41 % in forecast period 2025-2032.
-
Global Antibody Drug Conjugates (ADC) Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 7.13 USD Billion in the year 2024.
- Retail Sales is the Fastest growing segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.62 % in forecast period 2025-2032.
-
Global Antibody Drug Conjugates (ADC) Market to 2032, By Linkers Component
- Cleavable Linkers is the largest segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 8.54 USD Billion in the year 2024.
- Cleavable Linkers is the Fastest growing segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.63 % in forecast period 2025-2032.
-
Global Antibody Drug Conjugates (ADC) Market to 2032, By Cytotoxic Payloads or Warheads Component
- DNA Damaging Agents is the largest segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 6.75 USD Billion in the year 2024.
- DNA Damaging Agents is the Fastest growing segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.67 % in forecast period 2025-2032.
-
Global Antibody Drug Conjugates (ADC) Market to 2032, By Linker Technology
- Peptide Linkers is the largest segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 6.59 USD Billion in the year 2024.
- Peptide Linkers is the Fastest growing segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.68 % in forecast period 2025-2032.
-
Global Antibody Drug Conjugates (ADC) Market to 2032, By Antibody Component
- Third Generation ADCs is the largest segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 6.05 USD Billion in the year 2024.
- Third Generation ADCs is the Fastest growing segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.76 % in forecast period 2025-2032.
-
Global Antibody Drug Conjugates (ADC) Market to 2032, By Antigen Component
- HER2 Receptor is the largest segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a revenue of 6.42 USD Billion in the year 2024.
- HER2 Receptor is the Fastest growing segment in Global Antibody Drug Conjugates (ADC) Market to 2032 with a Growth rate of 15.97 % in forecast period 2025-2032.
Global Antibody Drug Conjugates (ADC) Market Company Share Analysis
| Company Name |
|
||
| Takeda Pharmaceutical Company Limited | |||
| Astellas Pharma Inc. | |||
| Gilead Sciences, Inc. | |||
| DAIICHI SANKYO COMPANY, LIMITED | |||
| F. Hoffmann-La Roche Ltd. | |||
Global Antibody Drug Conjugates (ADC) Market Geographical Sales Distribution, 2018-2032 USD Billion
Global Antibody Drug Conjugates (ADC) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Global Antibody Drug Conjugates (ADC) Market is segmented based on Segmentation Conjugation Technology,End User,Indication,Product,Distribution Channel,Linkers Component,Cytotoxic Payloads or Warheads Component,Linker Technology,Antibody Component,Antigen Component.
Global Antibody Drug Conjugates (ADC) Market was valued at USD 10.77(Revenue in USD Billion) in 2023.
Global Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 15.59% during the forecast period of 2024 to 2032.
The Cleavable Linkers segment is expected to dominate the Global Antibody Drug Conjugates (ADC) Market, holding a largest market share of 8.54 USD Billion in 2024
Coming Soon....
Global Antibody Drug Conjugates (ADC) Market Scope
Global Antibody Drug Conjugates (ADC) Market Segmentation & Scope
Conjugation Technology
- Chemical Conjugation
- Site-Specific Conjugation
End User
- Hospitals
- Specialty Center
- Clinics
- Ambulatory Centers
- Home Healthcare
- Others
Indication
- Others
- Genitourinary Cancer
- Gastrointestinal Cancer
- Gynecological Cancer
- Lung Cancer
- Blood Cancer (Leukemia, Lymphoma)
- Breast Cancer
Product
- Enhertu
- Kadcyla
- Trodelvy
- Polivy
- Adcetris
- Padcev
- Besponsa
- Elahere
- Zylonta
- Mylotarg
- Tivdak
- Others
Distribution Channel
- Others
- Retail Sales
- Direct Tenders
Linkers Component
- Non Cleavable Linkers
- Cleavable Linkers
Cytotoxic Payloads or Warheads Component
- DNA Damaging Agents
- Microtubule Disrupting Agents
Linker Technology
- Peptide Linkers
- Thioether Linkers
- Hydrazone Linkers
- Disulfide Linkers
Antibody Component
- First Generation ADCs
- Third Generation ADCs
- Second Generation ADCs
- Fourth Generation ADCs
Antigen Component
- HER2 Receptor
- Trop-2
- CD79B
- CD30
- Nectin 4
- CD19
- CD33
- Tissue Factors
- Others
- CD22
Frequently Asked Questions
The Global Antibody Drug Conjugates (ADC) Market is segmented based on Segmentation Conjugation Technology,End User,Indication,Product,Distribution Channel,Linkers Component,Cytotoxic Payloads or Warheads Component,Linker Technology,Antibody Component,Antigen Component.
Global Antibody Drug Conjugates (ADC) Market was valued at USD 10.77(Revenue in USD Billion) in 2023.
Global Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 15.59% during the forecast period of 2024 to 2032.
The estimated market value of the Global Antibody Drug Conjugates (ADC) Market for final year is USD 34.32 (USD Billion).
Global Antibody Drug Conjugates (ADC) Market Company Profiling
Frequently Asked Questions
The Global Antibody Drug Conjugates (ADC) Market is segmented based on Segmentation Conjugation Technology,End User,Indication,Product,Distribution Channel,Linkers Component,Cytotoxic Payloads or Warheads Component,Linker Technology,Antibody Component,Antigen Component.
Global Antibody Drug Conjugates (ADC) Market was valued at USD 10.77(Revenue in USD Billion) in 2023.
Global Antibody Drug Conjugates (ADC) Market is projected to grow at a CAGR of 15.59% during the forecast period of 2024 to 2032.
The estimated market value of the Global Antibody Drug Conjugates (ADC) Market for final year is USD 34.32 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.